Content related to A Simple Plasma-Based Biomarker Could Predict Liver Fibrosis in Latino Adolescents With Obesity

The Southern California Center for Latino Health tackles health disparities in children to prevent the development of chronic diseases in adults.

Dr. Bhattacharjee is investigating potential therapies for the most severe form of fatty liver disease: metabolic dysfunction-associated steatohepatitis.

A CHLA expert explains the symptoms, causes and treatments for nonalcoholic fatty liver disease in children

Children’s Hospital Los Angeles dedicates annual research symposium events to childhood obesity as a driver of chronic lifetime health issues including diabetes, heart disease and liver disease.

A new class of drugs can relieve itching for cholestatic childhood liver disease and potentially lengthen time until a liver transplant is necessary.

New clinical practice update advises on intestinal ultrasound use in treating Crohn’s disease and ulcerative colitis.

Receiving a liver transplant means also living with the possibility of rejection. Transplant rejection occurs when the body’s immune system attacks the new organ. This risk is highest in the first

Children’s Hospital Los Angeles researchers develop app to predict if children with acute liver failure will need an urgent liver transplant or can recover on their own.

Study finds that T-cells expressing PD-1 may help predict recovery in children with acute liver failure.